Researchers present results of The Heart of New Ulm Project at AHA Scientific Sessions

Researchers from Allina Health and the Minneapolis Heart Institute Foundation have presented on the results and implications of The Heart of New Ulm Project on heart disease risk factors at the American Heart Association Scientific Sessions in Chicago, Ill.

The Heart of New Ulm is a 10-year community intervention aimed at reducing the rate of modifiable cardiovascular disease risk factors in a rural community through interventions delivered through clinical, worksite, and broader community settings with goals of improving lifestyle changes, clinical care, and the environment where community members work and play. Interventions include heart health screenings, health coaching, worksite health improvement programs, improving the food environment with restaurants and farmers markets, and increasing the opportunities for physical activity in the community.

In the first study, a research team examined how CVD risk factors had changed over the first five years of the project. Significant improvements were identified for blood pressure and lipids at the population level. The percentage of residents with blood pressure at goal increased from 78.7 percent to 84.3 percent, and the percentage with LDL cholesterol at goal increased from 68 percent to 72 percent. No significant changes were noted in BMI, glucose and smoking. These population-level improvements were driven primarily by better risk factor control among those who were not at goal when the project began.

In the second study, a research team examined whether short-term changes in lifestyle factors had an effect on high density lipoprotein (HDL) and total cholesterol/HDL ratio. They found that weight loss was the strongest lifestyle predictor of increased HDL. Furthermore, quitting smoking and decreased physical activity were associated respectively with improved and poorer total cholesterol/HDL ratio.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients